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Highly pathogenic avian influenza (HPAI) virus H5N1 infects water and land fowl and can infect and cause
mortality in mammals, including humans. However, HPAI H5N1 strains are not equally virulent in mammals,
and some strains have been shown to cause only mild symptoms in experimental infections. Since most
experimental studies of the basis of virulence in mammals have been small in scale, we undertook a meta-
analysis of available experimental studies and used Bayesian graphical models (BGM) to increase the power
of inference. We applied text-mining techniques to identify 27 individual studies that experimentally deter-
mined pathogenicity in HPAI H5N1 strains comprising 69 complete genome sequences. Amino acid sequence
data in all 11 genes were coded as binary data for the presence or absence of mutations related to virulence in
mammals or nonconsensus residues. Sites previously implicated as virulence determinants were examined for
association with virulence in mammals in this data set, and the sites with the most significant association were
selected for further BGM analysis. The analyses show that virulence in mammals is a complex genetic trait
directly influenced by mutations in polymerase basic 1 (PB1) and PB2, nonstructural 1 (NS1), and hemag-
glutinin (HA) genes. Several intra- and intersegment correlations were also found, and we postulate that there
may be two separate virulence mechanisms involving particular combinations of polymerase and NS1 muta-
tions or of NS1 and HA mutations.
H5N1 avian influenza initially garnered widespread atten-
tion following the first human cases of infection recorded in
Hong Kong in 1997, after an outbreak in chickens (15, 72, 74),
which itself followed an earlier infection in water fowl (21, 84).
Since then the virus has spread across Asia to Russia, the
Middle East, Europe, and Africa, causing deaths in wild
aquatic birds (13, 58, 71, 81), domestic ducks and chickens (29,
39, 43), dogs and cats (2, 35, 36, 55, 76), and 254 of 405
confirmed human cases as of 5 February 2009 according to
the World Health Organization (http://www.who.int/csr/disease
/avian_influenza/).
Avian influenza virus strains are classified as highly patho-
genic or of low pathogenicity on the basis of their virulence in
chickens—highly pathogenic avian influenza (HPAI) virus can
cause significant mortality (75 to 100%) in unvaccinated flocks
(see reference 1), whereas low-pathogenicity strains cause only
mild or no symptoms. HPAI H5N1 strains possess multiple
basic amino acids in the hemagglutinin (HA) surface glyco-
protein (27) cleavage site, the characteristic of all HPAI (62,
63). A variety of substrains of HPAI H5N1 have appeared
during the last 10 years (82) and have probably become en-
demic in both wild birds and poultry (12, 43, 58). All strains of
HPAI H5N1 are highly pathogenic in chickens, but their viru-
lence varies in ducks (29) and mammals (see for example,
references 11, 20, and 34).
The influenza A virus has an eight-segment RNA genome
encoding 11 proteins, and the effects of point mutations or
allelic combinations on the virulence of HPAI H5N1 isolates in
mammals have been measured in mammals by reverse genetics
and reassortment studies. Virulence in mammals is thought to
be polygenic (10, 20), and several experimental studies have
shown that mutations in the genes encoding internal proteins
are important virulence determinants. For example, E627K in
PB2 was shown to be important for replication in mammalian
cells (73) and in the difference in virulence of two H5N1 Hong
Kong 1997 outbreak isolates (24), whereas D92E in NS1 was
found to increase resistance to tumor necrosis factor alpha and
gamma interferon host responses for another H5N1 Hong
Kong 1997 strain in vitro and in vivo in one study in swine (67).
Given the diversity of H5N1 viruses, their high rates of
mutation and reassortment (14, 21, 22, 68, 77), and the poly-
genic nature of their virulence in mammals, general conclu-
sions about virulence factors cannot be drawn with confidence
from individual studies of small numbers of closely related
sequences. However, systematically amalgamating the results
from several studies may allow a more comprehensive picture
to emerge. Such integration of results from many experiments
and assays to provide a more complete understanding of gene-
protein interactions has been carried out in Saccharomyces
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cerevisiae (32, 40, 65). Using multiple data sources reduces the
number of false-positive results and can reveal new patterns of
association (32, 40), provided data quality and content issues
are overcome (see for example, reference 56). Furthermore,
while assembly of a few large data sets into a form suitable for
meta-analysis can be done manually, experimental results from
many small individual studies can also be captured by text
mining published abstracts from online databases such as
PubMed at the National Center for Biotechnology Information
(NCBI) (51, 69).
The aim of the present study was to find a statistical model
to describe the amino acid sites important for virulence of
HPAI H5N1 in mammals and to indicate possible interactions
between the sites. We have text mined PubMed abstracts for
H5N1 isolates with experimentally determined virulence in
mammals and downloaded the corresponding full genome se-
quences from the NCBI Influenza Virus Resource (4). We
then fitted a Bayesian graphical model (BGM) to capture the
dependencies among mutations and between individual muta-
tions and the mammalian virulence phenotype. BGMs repre-
sent the probabilistic dependencies between random variables
as a network without self-references, i.e., a directed acyclic
graph (37, 59). They provide a convenient description of mul-
tivariate data because each link encodes a direct probabilistic
dependency between sampled variables (e.g., A  C), rather
than just a correlation (e.g., A C, because A B and B C).
BGMs have been used in several biological contexts: to infer
gene expression networks from microarray data (18), to find
the genes involved in a complex trait using single nucleotide
polymorphism data (66), and to find coevolving sites in a rap-
idly variable region of a human immunodeficiency virus (HIV)
gene (61). In the present study the nodes (random variables) in
the network represent variable amino acid sites or the pheno-
type: links between nodes represent direct dependencies, i.e.,
links between amino acid sites represent putative functional
interactions, and links between amino acid sites and the phe-
notype of “virulence in mammals” represent direct association
of specific mutations and virulence.
MATERIALS AND METHODS
Text mining. A list of H5N1 HPAI isolates with experimentally determined
virulence in mammals was obtained by using a text-mining approach, followed by
manual curation. Initially, XML (Extensible Markup Language) records of all
abstracts containing “H5N1” and “virulence” keywords were obtained from
PubMed using Eutils queries (http://www.ncbi.nlm.nih.gov/entrez/query/static
/eutils_help.html) generated with R scripts (http://www.r-project.org). Each of
the 542 abstracts obtained on 5 March 08 were searched for isolate names (such
as A/Vietnam/1203/2004) using a “/(words)/(words)/” regular expression (i.e., at
least three “/”s). This yielded 185 isolate names in 97 abstracts. Next, a list was
compiled (using R scripts and manual editing) of unique isolate names, taking
into account synonyms (e.g., dk  duck) and recording the PubMed identifiers
(PMIDs) of papers that had mentioned the strain. Of the 94 unique isolate
names found, 64 were for H5N1 isolates with measured virulence in mammals
and full genome sequences deposited in the NCBI Flu database (4) (http://www
.ncbi.nlm.nih.gov/genomes/FLU/FLU.html).
The abstracts corresponding to the 64 H5N1 isolates were examined, and
detailed results from mice or ferret studies were manually extracted from the
corresponding studies. In some studies additional strains not mentioned in the
abstract had also been studied, and these strains were also added to the original
list, bringing the total to 69 strains from 27 individual studies. Table SA1 in the
supplemental material contains the references to the studies and the numbers of
strains from each study in the final data set. Each strain was manually classified
as either virulent or nonvirulent in mammals based upon the amalgamated
experimental evidence. Table SA2 in the supplemental material contains the
assigned classification and experimental evidence per strain.
Data preprocessing. Full genome nucleotide sequences of the 69 isolates with
experimental evidence for (or against) virulence in mammals were downloaded
from the NCBI Flu Database. The individual segments were initially aligned by
using CLUSTAL W in BioEdit, and then a final manual codon alignment was
performed in MEGA 4.0. The PB1-F2, M2, and NS2 coding sequences were
manually extracted from the aligned nucleotide files (not all strains were anno-
tated for these alternative coding sequences), and all 11 nucleotide coding
sequences were translated to protein sequences in MEGA 4.0.
To analyze the association of particular residues at amino acid sites and
virulence using BGMs, the protein sequences were converted into a binary
matrix where each row of the matrix represented an isolate genome (11 proteins
concatenated), and columns represented amino acid sites. An additional column
for the virulence phenotype was added. Zeros represented consensus amino acid
residues, ones represented any mutant (or the virulent phenotype). In particular,
the following procedure was used to determine the binary coding at each variable
site (via a custom R script). (i) If there are only two types of amino acids present
at a site (A or B), a 22 table was calculated, counting the number of A residues
in the virulent sequences, V(A); the number of A’s in nonvirulent sequences,
N(A); the number of B’s in virulent sequences, V(B); and the number of B’s in
nonvirulent sequences, N(B). (ii) To determine which to code as 1, A or B, the
determinant of the 22 table was calculated as V(A)N(B) – V(B)N(A). If the
determinant is positive, then amino acids of type A are coded as 1’s and the B’s
are coded as 0’s (and vice versa for negative determinants). Alternatively, if there
is evidence in the literature to indicate that a particular residue is related to
virulence (or nonvirulence), then this residue is coded as 1 (or 0). (iii) If there are
more than two types of residue at a site, then step 2 is repeated for all combi-
nations of amino acids partitioned into two groups, and the combination with the
smallest P value from the Fisher exact test on the 22 table is chosen.
The coding scheme used, corresponding 22 table entries and P value from
the Fisher exact test for sites of interest are reported in Table 1 (see Table SA3
in the supplemental material for information on all of the sites examined).
Multivariate analysis of variable amino acids. (i) BGMs. BGMs were inferred
by using HyPhy (60, 61) from sequence and phenotype data coded to a binary
matrix. HyPhy implements the methods of Cooper and Herskovits (16) and
Friedman and Koller (19) for BGM inference as follows. The probability for a
particular graph structure given the data can be calculated by using the K2
scoring metric (16). The K2 metric score for one node is a function of the number
of discrete states of the node and its parents (e.g., how many B  1 when A 
1, etc.), and the total score for the graph is the product of the individual node
scores. When the number of nodes is nontrivial (typically greater than 5), eval-
uating all possible graph structures becomes prohibitive so the Monte Carlo
Markov chain (MCMC) method is used over families of ordered nodes to find a
set of probable graph structures to describe the data (19). The output of the
BGM inference is a consensus graph, where each link is assigned a probability of
existing according to how often it appears in the sampled MCMC results (i.e., the
marginal posterior probability  the expectation of posterior probabilities
weighted by the likelihoods of the node orderings in which the given link ap-
pears). Links with probability greater than or equal to 0.5 in the consensus graph
are used to create the final network.
For analysis of the 69 sequence data set (with 10 nodes), the HyPhy BGM
MCMC was run with 106 steps (after a burn-in of 105 steps) and sampled every
1,000 steps. These parameters were chosen so that the sampled likelihood values
were converged to a stationary distribution, and the individual samples were
independent (the autocorrelation of the sampled likelihood values was calcu-
lated in every run, and the values of the first lags were not significantly different
from zero). The maximum number of parents allowed per node was increased
until there was no significant change in network structure (i.e., no new links
where P  0.5 occurred), and a maximum of five parents per node was found to
be sufficient for the present data set.
(ii) Model validation. The significance of the links in the BGM inferred from
the 69  10 binary data matrix was tested in two ways.
(a) The inferred BGM was compared to a set of null model BGMs. Null
models were generated by inferring BGMs from nonparametrically bootstrapped
data in which one site (or phenotype) was randomly permuted (i.e., a fixed
column in a matrix of observation was resampled without replacement) at a time
(leaving the other sites unchanged). Ten randomizations were performed per site
(i.e., one-hundred randomizations for the ten sites). Randomizing each site (or
the phenotype) independently of the others and inferring the BGM gives the
background probability of the links between that site and the others due to
random noise alone, conditional upon the joint probabilistic structure of the
remaining data. The unpermuted BGM link probabilities from the site of interest
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to or from the other sites were normalized by the mean and standard deviation
of the 10 permuted results to give a standard score per link.
(b) Cross-validation of structure was applied. To test the robustness of the
inferred BGM and mitigate any possible effects from isolate misclassification or
sequencing errors, 10 BGMs were calculated and averaged over different subsets
of the data. Each subset of data consisted of 65 sequences (i.e., training data),
and the 4 remaining sequences were kept as test sets. Since a different group of
strains (particularly the Z constellation) began to replace the early strains from
2002 onward (11, 22, 43), different patterns of mutations may occur after 2002;
hence, four sequences were excluded in each run, one from each of the pre-2002
(early) virulent, 2002 (late) virulent, pre-2002 nonvirulent, and 2002 nonviru-
lent sequences.
(iii) Conditional probability tables. Conditional probability tables describing
the probability that a strain is virulent (nonvirulent) given the presence or
absence of mutations at individual sites (identified in the BGM as directly
influencing virulence), or a combination of those sites, were calculated separately
for each of the 10 cross-validation training data sets using the observed frequency
of mutations. Certain combinations of mutations in the influencing sites were not
observed because of the correlation between the sites (e.g., there were no se-
quences in the 69 sequence set with PB1-317  1 and NS1-92  0 or vice versa).
For (hypothetical) strains with these unobserved combinations, we estimated the
probability of virulence from the probability of virulence of the individual sites,
assuming that the sites were independent as in equation 1 below.
PVir 1a1a2a3 1
i1
3
1 piai (1)
where P(Vir  1a1a2a3) is the probability of virulence for a sequence with the
particular combination a1a2a3 of amino acids, and pi(ai) is the probability of
virulence when node i has amino acid i.
The performance of the model was examined by predicting the virulence of the
sequences in each of the 10 training and test data set pairs using the conditional
probability table derived from each training set, respectively. The numbers of
true positives (TP; virulent sequences predicted to be virulent by the model),
false negatives (FN; virulent sequences predicted as nonvirulent), false positives
(FP; nonvirulent sequences predicted as virulent), and true negatives (TN; non-
virulent sequences predicted as nonvirulent) were calculated along with the misclas-
sification (FP  FN), sensitivity [TP/(TP  FN)], and specificity [TN/(FP  TN)]
values.
RESULTS
Isolates with experimentally determined virulence in mam-
mals. A total of 69 H5N1 full-genome isolates from 27 studies
of virulence in mammals identified using a text-mining ap-
proach, followed by manual curation, were used in this analysis
(see Materials and Methods and Table SA1 in the supplemen-
tal material). The most frequently measured strain—A/Viet-
nam/1203/04—was the subject of seven virulence studies. Five
studies (11, 20, 34, 47, 50) contained measurements for at least
five sequences. Strains were classified as virulent (or nonviru-
lent) if infection studies showed a high mortality with a low
dose; sequences with 50% lethal dose of 103 50% egg infec-
tious doses were classified as virulent in mammals. Even
though the virulence results were obtained in different animals
and using different protocols, the results were generally con-
cordant: in 75% of cases (52 sequences), strains could be clas-
sified clearly either as highly pathogenic in mice or ferrets or
only caused mild or no symptoms. Furthermore, three studies
measured virulence in both mice and ferrets (28, 50, 64) in a
total of five strains. In these cases, the pathogenicity in ferrets
correlated with that in mice (highly pathogenic strains in fer-
rets were highly pathogenic in mice, low-pathogenicity strains
in ferrets showed low pathogenicity in mice). Although differ-
ences in the virulence of two H5N1 strains in mice and ferrets
TABLE 1. Amino acid site coding and P value for association with virulence using the Fisher exact testa
Site
Residue(s)
P Selected Reference(s) Additional detail(s)
Virulent Nonvirulent
PB2-318 K R 0.0027 * 10
PB2-355 K R, Q 0.0003 (PB1-317) 10, 34, 41
PB2-627 K E 0.0034 * 10, 11, 24, 41
PB2-627 or 701 K, N E, D 0.0003 (*) 17, 38, 70
PB1-317 I M, V 3.8E-05 * 10, 34, 41
PA-127 I V 0.0007 (PB2-318) 75
PA-336 M L 0.0006 (PB2-318) 75
HA-102 (86E) V A, I, P, S, T 0.0092 * 83
HA-140 (124B) S N, D 0.0431 83
HA-154 (138A) L, N Q, H, I 0.0391 83
HA-172 (156 glyco) T, S A 0.0010 * 8, 10, 83
HA-228 (212D) E, R K 0.0194 * 83
HA-279 (263E) T A 1.8E-05 * 83
NA-49:72 Any deletion No deletion 0.0003 * 5, 52 Stalk deletion
NS1-42 S A, P 0.0244 33 P attenuates pathogenicity
NS1-92 E D 0.0010 * 41, 67
NS1-92/97 E D 0.0504 48 D92E (no deletion) or D97E
(with deletion)
NS1-127 N T, D, R, V, A 0.0387 53 123-127 PKR region
NS1-189 N D, G 0.0006 (PB2-318) 75
NS1-195 T, Y S 0.0294 (HA-102) 7
NS1-228 P S 0.0027 (NS1-92) 31, 57 PDZ binding domain
NS2-31 I M 0.0006 (PB2-318) 75
NS2-56 Y H, L 0.0006 (PB2-318) 75
a For each sequence, sites containing the “virulent” residues (column 2) were coded as ones or zeros (column 3). The numbers of sequences classified as virulent
(nonvirulent) with virulent (nonvirulent) residues were calculated, and the P value from the Fisher exact test (uncorrected) is displayed in column 4. The nine sites with
the lowest P values selected for further analysis are indicated by an asterisk in column 5; sites with the same (or similar) pattern of mutations to selected sites are also
indicated in column 5. All site numbering is from the first methionine in the coding sequences. The numbers in parentheses for HA correspond to the mature H5 site
numbers, as in reference 83, and the letters correspond to the canonical antigenic site, or a glycosylation site (glyco). Abbreviations: PB, polymerase basic; NP,
nucleoprotein; NA, neuraminidase; M, matrix protein; NS, nonstructural protein.
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at high dose have been reported (86), we did not find signifi-
cant differences in the overall virulence of the strains in the
present data set when we used our binary classification scheme.
Details of the strain classification and associated experimental
evidence can be found in Table SA2 in the supplemental ma-
terial.
The final full data set consisted of 69 full genome sequences:
35 from water fowl, 17 from land fowl, and 17 from humans.
Totals of 20% (7) of the water fowl isolates, 24% (4) of the
land fowl isolates, and 65% (11) of the human sequences were
classified as virulent in mammals, making a total of 22 virulent
sequences. The distribution of the strains across isolation year
and place is shown in Fig. 1: this data set covers several out-
breaks, including the 1997 Hong Kong, 2000 to 2002 China,
and 2004 Viet Nam epidemics.
Site association with virulence. Across the whole genome,
1,235 of 4,582 (	27%) amino acid sites were variable (1
alternative residue in the 69 sequences) with 969 of 1,235
(	78%) of these variable sites containing only 2 amino acid
residues. Furthermore, in the remaining 266 (22%) of variable
sites that coded for three or more alternative amino acids, the
average frequency of the next most abundant residue was only
4%. To facilitate analysis of the relationship between muta-
tions and virulence in mammals, the sequence data were coded
to a binary matrix, which therefore retained almost all of the
information contained in the sequence alignment.
All 1,235 polymorphic amino acid sites in the protein se-
quences of the 69 strains were examined, and the distribution
of the alternative residues among strains classified as virulent
or nonvirulent was recorded. A total of 227 amino acid sites
(19% of the variable sites) across the entire genome were
found to have an association with virulence at P 0.05 (Fisher
exact test, uncorrected). However, there was a high degree of
association among sites, with mutations at 129 sites having an
identical distribution across the strains to at least one other
site. Of the 98 sites with a distribution that was unique in the
data set, only 53 differed by more than one mutation from any
other site. Of the 98 sites with a unique distribution, 12 have
been reported in the literature to have functional significance
for virulence (see Table SA3 in the supplemental material).
We next examined all amino acid sites or genomic features
(e.g., neuraminidase [NA] stalk deletion; PDZ binding domain
in NS1) previously reported in the literature as having func-
tional significance for virulence in H5N1 and found evidence
for 70 sites/features. Their distribution among virulent and
nonvirulent strains was tested as described above: the 23 that
were apparently associated with virulence in this data set are
shown in Table 1 (Fisher exact test P  0.05, uncorrected; see
Table SA3 in the supplemental material for details of all 70
sites). All of the strains in this data set, including nonvirulent
ones, contained the HA-226(Q) and HA-228(G) (H3 number-
ing) residues for the avian sialic acid receptor binding site (23,
30) and the NS1-149(A) virulence determinant in chickens
(45); on the other hand, only one strain contained the patho-
genicity-associated proline at amino acid site 42 in NS1 (33).
Of the 23 sites, three in PB2 (sites 318, 355, and 627), one in
PB1 (site 317) and one in NS1 (site 92) which were apparently
associated with virulence (P 
 0.01; Table 1) had previously
been claimed to have a role in virulence determination (see the
Discussion). In addition, the presence of PB2-701N has been
suggested as an alternative virulence or adaptation marker in
mammals in place of PB2-627K (17, 38, 70), and combining
the PB2-627 and PB2-701 sites resulted in a more significant
P value (P  0.0003) for association with virulence than PB2-
627 (P  0.003) or PB2-701 (P  0.08) alone. A further five
sites in polymerase acidic (PA), and nonstructural genes (NS1
and NS2) were also nominally significant; however, these sites
had very similar distributions across strains to PB2-318. Two
HA antigenic sites—HA-102(mature H5 site 86, part of canon-
ical antigenic site E) and HA-279(263E) and the glycosylation
site HA-172(156)—had a possible association with virulence
(P
 0.01), and deletions in the NA stalk region appeared to be
quite strongly associated: 21 of the 22 virulent sequences
showed stalk deletion compared to about half of the nonviru-
lent sequences (P 
 0.001).
Site selection for BGM. The uncorrected associations are
not themselves evidence of causal dependencies but assist with
the selection of sites to be analyzed in the multivariate model.
Sites with the same (or only one mutation different) pattern
across the sequences were combined since the individual con-
tribution of these sites to virulence would not be distinguish-
able from this data set. The sites with common patterns are
shown in Table 2. Of the 23 sites and/or features with Fisher
exact test P values of 0.05, only 13 had distinct patterns. In
order to reduce the possibility of inferring false links, the total
number of variables included in the BGM analysis was re-
stricted as indicated by simulation studies based on sample
sizes of 60 to 70 strains (see the discussion of simulation analy-
sis in the supplemental material). Consequently, the nine
TABLE 2. Amino acid sites with similar patterns of mutationsa
Pattern Sites (virulentnonvirulent)
1 ............................PB2-318(KR), PA-127(IV), PA-336(ML),
NS1-189(NDG), NS2-31(IM), NS2-56(YLH)
2 ............................PB2-355(KRQ), PB1-317(IMV)
3 ............................PB2-675(LI), PB2-683(TA), PB1-198(KR),
NA-39(QHK), NA-223(IT)
4 ............................HA-102(VAIPST), NS1-195(TYS)
5 ............................NS1-92(ED), NS1-228(PS)
6 ............................M2-64(SAFP), M2-69(PL)
a The distributions of mutations across strains for sites identified in the liter-
ature (see Table 1 and Table SA3 in the supplemental material) were examined.
These groups of sites have more than one mutation and identical or nearly
identical distributions (1 mutation difference).
FIG. 1. Distribution of full-genome isolates in text-mined data
across isolation year and region. The total number of isolates in the
data set per year is indicated by the height of the bars, and the
distribution by region is represented by the bar colors. The data covers
three major outbreaks: Hong Kong in 1997, Hong Kong/China in 2001,
Vietnam (plus others) in 2004 over a period of at least 10 years.
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uniquely patterned sites with the most significant P values for
association with virulence in mammals (ranging from P
 104
to P  0.019), together with the virulence phenotype, were
included in the multivariate analysis (Table 3). The selected
sites were: PB2-318, PB2-627, PB1-317 (' PB2-355), HA-102
(' NS1-195), HA-172, HA-228, HA-279, NA stalk deletion,
and NS1-92 (' NS1-228) (the final binary data used can be
found in Table SA4 in the supplemental material). Since there
is evidence in the literature to suggest that PB2-701N may
compensate for the lack of PB2-627K in the adaptation of the
virus to mammals (17, 38, 70), we also investigated the effect of
using the combined PB2-627 and PB2-701 site data in place
of PB2-627 alone.
BGM results. BGMs were inferred from the binary data of
the selected sites using: (i) all 69 sequences; (ii) 100 cases of
permuted binary data (null models) and; (iii) 10 cases of leav-
ing 4 sequences out each time (10 cross validation, see the
discussion of model validation in Materials and Methods).
Figure 2 shows the inferred network structure for significant
links, together with the average link probability from the 10
cross validation and standard score from the comparison to the
null model networks. The model confirms that virulence in
mammals is a complex genetic trait affected directly by muta-
tions in the polymerase, NS1, and HA genes.
Very strong correlations among certain sites leave some
ambiguity over the precise nature of the molecular changes
since these sites could not be analyzed separately (Table 2).
Specifically, three distinct mutation patterns, representing two
sites each—PB1-317/PB2-355, NS1-92/NS1-228, and HA-102/
NS1-195—were directly associated with virulence in mammals
in the model. We did not detect a significant direct association
of PB2-627 alone with virulence in mammals in the model;
however, a strong direct association, with a probability of 0.8
(standard score  3 to 4) was detected for the combined sites
PB2-627 and PB2-701 (data not shown).
Sites within the polymerase genes were strongly associated
with each other in the model: the pattern 1 sites (including
PB2-318, PA-127, and PA-336) were linked to PB1-317/PB2-
355 pattern 2 sites with a probability of0.9 (standard score 
9 to 10). Strong intrasegment associations were also found in
both HA and NS, particularly between antigenic sites HA-102
and HA-279, HA-102 and the variable glycosylation site HA-
172, and NS1-92 and NS1-228 (pattern 5) and between NS1-
189, NS2-31, and NS2-56 (pattern 1). The most significant
intersegment association was between PB1-317/PB2-355 (pat-
tern 2) and NS1-92/228 (pattern 5). NS1 sites 92, 195, and 228
were also strongly associated with HA-279 (antigenic site), and
NS1-189 had the same pattern as the PB2-318, PA, and NS2
sites (pattern 1). Additionally, the previously reported interac-
tion between the HA-172(156) glycosylation site and the NA
stalk deletion (3) was detected in the BGM with a probability
of 0.8 (standard score  9 to 10).
The model was tested by using cross-validation (see Mate-
rials and Methods). Table 4 and Table 5 show the conditional
probabilities for virulence in mammals averaged over each
training data case from the cross-validation data sets, calcu-
lated per single influencing node (Table 4) and per combina-
tion of influencing sites (Table 5). Where a particular combi-
nation of amino acids has not occurred in this data set (due to
the small data set size and interactions between the influencing
sites), the probability of virulence in Table 5 was estimated by
combining the individual probabilities in Table 4, assuming
independence among sites (see the discussion of conditional
probability tables in Materials and Methods).
Using the conditional probability tables from the 10 train-
ing data examples, virulence predictions were made for each
test data example (these were composed of the four ex-
cluded sequences from the training data: one of each early-
FIG. 2. Inferred BGM for virulence in mammals. The indicated
link probabilities from 10 cross validation and z-score from compar-
ison to null models (in parentheses) are rounded down, e.g., “0.8 (3)”
means a link probability of 0.8 to 0.9 and a z-score of 3 to 4. Note that
some nodes represent more than one site, as listed in Table 2. The sites
directly associated with virulence in mammals are PB1-317/PB2-355,
NS1-92/NS1-228, and HA-102/NS1-19.
TABLE 3. Sites selected for BGMa
Site (virulentnonvirulent) Comment(s)
Vir “Virulent-in-mammals”
phenotype
PB2-318(KR)  Combined pattern 1, see Table 2
PB1-317(IMV)/PB2-355(KRQ) Combined pattern 2, see Table 2
PB2-627(KE)
HA-102(VAIPST)/NS1-195(TYS) Combined pattern 4, see Table 2
HA-172(TSA)
HA-228(ERK)
HA-279(TA)
NA-del NA stalk deletion (“1”) or no
deletion (“0”)
NS1-92(ED)/NS1-228(PS) Combined pattern 5, see Table 2
a The sites included in the BGM analysis were the nine sites with the most
significant P values for association with virulence in mammals, and the “virulent-
in-mammals” phenotype. Sites with the same distribution of mutations across the
strains are analyzed together as indicated.
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virulent, late-virulent, early-nonvirulent, and late-nonviru-
lent sequences, where early refers to a pre-2002 occurrence;
see the discussion of model validation in Materials and Meth-
ods for details). The average prediction performance over the
cross validation training and test data sets was calculated (Ta-
ble 6); for the test data, the sensitivity was 70%, and the
specificity was 95%.
DISCUSSION
This study combines results from previous experimental
studies based on strains isolated during 3 major HPAI H5N1
outbreaks in order to examine the genetic basis of virulence in
mammals. Extensive literature mining, followed by rigorous
quality control, identified 69 complete genome sequences with
experimentally determined virulence in mammals for use in
this analysis, a threefold increase from the number of se-
quences analyzed in the largest experimental study to date. We
have fitted for the first time a rigorous statistical model relating
mutations in multiple influenza viral segments to virulence in
mammals. Many authors have previously described virulence
in terms of a complex trait (10, 11, 20): the model presented
here confirms that virulence in mammals is affected by muta-
tions in at least four segments: PB1, PB2, HA, and NS1.
Univariate analyses. Three sites in PB2 (sites 318, 355, and
627), PB1-317 and NS1-92 that were apparently associated
with virulence in the univariate studies had been proposed in
earlier experimental studies (10, 11, 24, 34, 41, 50, 67). Recent
experimental evidence indicates that a PB2-701N mutation
may arise in mammals instead of PB2-627K (70); we found no
isolates containing both mutations in the 69-sequence data set,
and combining these two sites increases the association with
virulence. A further five sites in PA, NS1, and NS2 identified in
a study of the 1997 Hong Kong H5N1 human outbreak (75)
were also nominally significant; however, these sites had very
similar mutation patterns to PB2-318 and the “virulent” resi-
dues only appeared in the 1997 sequences. We did not detect
any significant association of NS1 deletions alone with viru-
lence in mammals in this data set (48). However, since NS1-
97E is a conserved residue (in the aligned sequences), the
5-amino-acid NS1-deletion also leads to an E at position 92 in
the protein (48), and NS1-92E (no deletion) or NS1-97E (with
deletion) with virulence in mammals was marginally significant
(P 	 0.05). The association of NS1-92E alone (aligned se-
quences) with virulence in mammals was more significant in
this data set (P 
 0.001). In addition, no significant associa-
tions between virulence in mammals and the Src homology 3
domain binding motifs or PDZ binding domains containing the
amino acid motif ESEV or EPEV in NS1 were found (26, 31,
57). However, proline at NS1-228 (part of the PDZ binding
domain) was associated with both virulence in mammals (P 

0.003) and strongly with E at NS1-92 (P 

 106).
Multivariate BGM models. The nine sites with the strongest
individual associations with virulence were included in the
BGM analysis, and three of them (PB1-317/PB2-355, NS1-92/
NS1-228 and HA-102/NS1-195) were found to have a direct
association with virulence.
The mutation patterns at PB1-317 and PB2-355 were very
similar to each other in the 69-sequence set and directly asso-
ciated with virulence in mammals. These mutations were first
identified by Katz et al. (34) as correlated with virulence in
mice in the 1997 Hong Kong outbreak. In this 69-sequence
data set, the PB1 (M,V)317I and PB2 (R,Q)355K “virulent”
TABLE 6. Average prediction performance over cross-validation
training and test data setsa
Data set
Avg performance (%)
Training Test
TP 13.6 (20.9) 1.4 (35)
FN 6.4 (9.8) 0.6 (15)
FP 2.9 (4.5) 0.1 (2.5)
TN 42.1 (64.7) 1.9 (47.5)
MC 9.3 (14.3) 0.7 (17.5)
a Each sequence in the training and test data sets was classified as virulent or
nonvirulent according to the combination of amino acids at PB1-317/PB2-355,
NS1-92/NS1-228, and HA-102/NS1-195 as in Table 5. The average numbers (or
percentages) of true positives (TP; virulent sequences classified as virulent), false
negatives (FN), false positives (FP), and true negatives (TN) from the 10 training
and test data sets, and the misclassification (MC) performance metrics are
indicated. The sensitivity and specificity values were 68% and 94%, respectively,
for the training data sets and 70% and 95%, respectively, for the test data sets.
TABLE 4. Conditional probabilities for “virulent-in-mammals”
sequences given individual sitesa
Node Sites Vir-AA Non-Vir AA P(virulenceVir-AA)
P(virulence
non-Vir
AA)
1 PB1-317/PB2-355 I/K MV/RQ 1.00 0.22
2 NS1-92/NS1-228 E/P D/S 0.73 0.22
3 HA-102/NS1-195 V/TY AIPST/S 0.69 0.24
a Given that a sequence has a “virulent” type amino acid (Vir-AA) at a site (as
indicated in column 3), the probability of that sequence having a “virulent”
classification is indicated in column 5. If the sequence has a “nonvirulent” amino
acid (Non-Vir AA) at a site (column 4), the probability of that sequence still
having a “virulent” classification is indicated in column 6. For example, if the
sequence contains PB1-317I (and/or PB2-355K), the probability of that sequence
being virulent is 1; if the sequence does not have these mutations, then the
probability of virulence is 0.22. All probabilities were calculated by averaging
over the 10 training data examples and assuming independence between sites
(rows).
TABLE 5. Conditional probabilities for “virulent in mammals”
sequences for combinations of sitesa
Nodeb
P(virulencestate)c
Virulence
prediction
(P  0.5)1 2 3
0 0 0 0.09 0
0 0 1 0.70 1
0 1 0 0.25 0
0 1 1 0.94* 1
1 0 0 1* 1
1 0 1 1* 1
1 1 0 1 1
1 1 1 1* 1
a A sequence with the combination of mutations “virulent” (1)/“nonvirulent”
(0) amino acids as indicated in columns 1 to 3 has a probability of virulence in
mammals as indicated in column 4. If the probability of virulence in mammals is
0.5, then the sequence is classified as ‘virulent’.
b Node 1, PB1-317/PB2-355; node 2, NS1-92/NS1-228; node 3, HA-102/
NS1-195.
c The values marked with an asterisk indicate that this particular combination
of mutations was not observed in the training data sets (or 69 sequence data set),
so the probability of virulence in mammals was estimated from the individual
values in Table 4 (see Materials and Methods). All probabilities were calculated
by averaging over the 10 training data examples.
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mutations only appear in sequences from the 1997 Hong Kong
outbreak. In an alignment of 579 full-genome sequences (rep-
resenting all H5N1 unique sequences deposited in the NCBI
Influenza Virus Resource as of September 2008), 44 sequences
contained one and 12 contained both of the mutations. Apart
from the 1997 Hong Kong outbreak, PB1-317I and/or PB2-
355K mutations were also present in sequences from birds in
China and Viet Nam in 2005 and 2006; a civet (Viet Nam
2005); and four human sequences (Indonesia 2006, China 2006
and 2007).
Two mutations in NS1, D92E and S228P, which were
strongly associated in the data set were also directly associated
with virulence in mammals in the BGM. The NS1 D92E
change is thought to influence pathogenicity by making the
virus more resistant to host interferon and tumor necrosis
factor alpha responses (67), thus inducing a more severe cyto-
kine response in the host (46). NS1-228 is one of the C-termi-
nal residues and part of a region that could bind proteins
containing PDZ domains. NS1 proteins with avian ESEV or
EPEV PDZ domain ligand motifs were postulated to disrupt
human cell pathways by binding to proteins with PDZ domains
(57), and NS1 proteins with avian PDZ domain ligands have
been shown to cause increased virulence in mice (31). A total
of 51 of the 69 sequences examined here contained ESEV or
EPEV at positions 227 to 230: no significant association of
these motifs with mammalian virulence was found. However,
the point mutation S228P was significantly associated with vir-
ulence in mammals. The NS1-92 and NS1-228 mutations re-
main correlated in the 579 H5N1 full genome sequence set.
There are 17 sequences with both mutations, the majority were
from the 1997 Hong Kong outbreak, but 3 were from isolated
from water fowl in Viet Nam 2005. Five sequences (one from
swine in China 2003 and four from birds in Viet Nam and
Russia 2005) contained the S228P mutation only, but no se-
quences contained only the D92E mutation. The BGM in-
ferred from the 69-sequence data set showed a strong link
between PB1-317/PB2-355 and NS1-92/NS1-228, and this as-
sociation still holds in the 579 full-genome data set (P 

 106
for the Fisher Exact test with the Bonferroni correction for
multiple testing between any of the 2,312 variable sites, i.e.,
2.67  106 pairwise interactions). All 12 sequences with both
PB1-317 and PB2-355 mutations also contained both NS1-92
and NS1-228 mutations. Hence, the model and wider results
indicate that the particular polymerase and NS1 gene combi-
nation significantly affects HPAI H5N1 virulence in mammals
and that a mutation pattern associated with virulence in mam-
mals in the 1997 Hong Kong outbreak has reemerged among
human H5N1 cases in Indonesia and China in 2006 and 2007.
The other mutations directly associated with virulence in the
BGM are NS1-195T and HA-102V. These sites are not
strongly linked in the model to the PB1, PB2, and NS1 sites
discussed above and may represent a separate mechanism for
enhanced virulence in mammals. NS1 sites S195, T197, and
D92 are hydrogen bonded in the NS1 crystal structure (6) and
make a cleft. It has been proposed that mutation D92E could
alter the phosphorylation of this NS1 cleft and thus affect
virulence (6, 44). The BGM results indicate that NS1-195 mu-
tations also affect virulence, and it is postulated that this could
be due to NS1-195 mutations changing the phosphorylation
properties of NS1, although clearly more experimental work is
required to investigate this as a possible mechanism. Interest-
ingly, the pattern of HA-102(86) V residues were completely
correlated with the NS1-195 T in the 69 sequence data set.
HA-102(86) is part of antigenic site E (83), so it is conceivable
that a mutation here could reduce any cross-immunity that
mammals may have against the virus. The correlation between
NS1-195T and HA-102V is highly significant in the 579 full-
genome sequence set (P 

 106 for the Fisher Exact test with
the Bonferroni correction), and there are 83 sequences with
both mutations, recorded from 2004 onward, mostly in Thai-
land, Viet Nam, and Russia. HA-102 is a highly polymorphic
site, with six different residues present in the 69-sequence set.
Of these, V (present in 10 isolates) and A (present in 55
isolates) are associated with virulence and nonvirulence in
mammals, respectively. The remaining four residues (I, P, S,
and T) are present in one isolate each, making a virulence
assignment on the basis of the 69 sequence data set alone
difficult. In the 579-sequence data set, residues I, P, and S were
rare and only present in 13 avian isolates in total. HA-102T, on
the other hand, was present in 48 isolates: 44 of the 48 human
isolates from Indonesia; a cat isolate from Indonesia, and 3
avian isolates from China. In the BGM, HA-102V was directly
associated with virulence with a link probability of 0.6 to 0.7
(standard score  3 to 4), and updating the binary coding
scheme for HA-102 to include T as a “virulent” residue in-
creases the link probability in the BGM to 0.8 to 0.9 (the
standard score remains 3 to 4). Consequently, HA-102 V or T
should be considered as a virulence marker.
At first sight, it is surprising that PB2-627 alone was not
found to be directly associated to virulence in mammals be-
cause this mutation is thought to be involved in adaptation to
mammalian hosts (73), has been previously reported as con-
tributing to virulence in the 1997 Hong Kong outbreak (10, 24,
25), and was shown to be important for efficient respiratory
tract growth in mammals (25). The sequence set used here
spanned more than the well-studied 1997 Hong Kong outbreak
and contained 6 PB2-627K virulent sequences (of 22 virulent
sequences), and 1 PB2-627K nonvirulent sequence (of 47). The
six virulent PB2-627K sequences were sampled in Hong Kong
in 1997 (2), Thailand and Viet Nam in 2004 (3), and Germany
in 2006 (1), whereas the single PB2-627K sequence classified as
nonvirulent was from A/Turkey/65596/2006 (a human case in
Turkey), which caused only mild symptoms in ferrets at a low
dose (85). In one of the cross-validation data sets, the PB2-
627K nonvirulent sequence was (randomly) excluded, and the
resulting BGM had a PB2-627-virulence link probability of 0.6.
However, using only sequences that were either very highly
pathogenic or nonpathogenic (75% of cases, 52 sequences), no
significant link was found between PB2-627K and virulence in
mammals. On the other hand, since it has been suggested that
a PB2-701D-to-N mutation may arise to compensate for a the
lack of the “virulent” PB2-627K residue in mammals (17, 38,
70), we combined the PB2-627 and PB2-701 sites, repeated the
analysis, and found a significant direct association between the
combined sites and virulence in mammals using BGMs (link
probability of 0.8, standard score  3 to 4). Although the
relationship between PB2-627K alone and virulence in mam-
mals was not found to be significant in the 69 sequence data
set, these results suggest that PB2-627K and PB2-701N might
be directly associated with virulence, but more isolates with
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these mutations and experimentally measured virulence in
mammals would be required to detect the associations unam-
biguously. In addition, more isolates would allow the putative
negative association between PB2-627K and PB2-701N to be
evaluated.
Even though the uncorrected P value from the Fisher exact
test for the association of NA stalk deletion and virulence in
mammals was 	0.0003, the BGM results did not show a direct
association. However, strong direct associations of NA stalk
deletion with HA-172(156, glycosylation site) and HA-279
(263, antigenic site) were inferred. HA and NA have comple-
mentary functions in viral replication (see Wagner et al. [78]
for a review), and various studies have indicated that the effects
of mutations in one can be compensated by mutations in the
other (52, 54, 79); consequently, some HA-NA associations are
to be expected. In particular, the NA stalk deletion–HA-172
glycosylation intersegment association (3) was confirmed by
the BGM in the present study. Both the association of HA-172
and NA stalk deletion and the HA-279 and NA stalk deletion
were significant in the 579-genome sequence set (Bonferroni-
corrected Fisher exact test result of P 
 106 for each). Nei-
ther the BGM nor the large sequence set provided any evi-
dence that HA-172 and HA-279 were associated with each
other (the corrected P value for the Fisher exact test on the
large sequence set was 1), so we deduce that the NA stalk
deletion is independently associated with both HA mutations,
indicating a functional interaction between HA and NA.
An underlying issue with analysis of genetic determinants in
influenza is the general lack of recombination within segments
and consequent strong associations of amino acid variants over
evolutionary time. Among the 228 sites with P  0.05 for
association with virulence in the 69-sequence data set, the high
degree of correlation in patterns of mutation is largely due to
identity by descent of the viral genome segments. Thus, 34 sites
have most or all of their “virulent” residues in the 11 sequences
isolated in the 1997 Hong Kong outbreak, 15 sites on segment
8 have mostly “virulent” residues except in the Goose/Guang-
dong/96 and 1999-2001 NS allele B sequences (9, 21, 49), and
7 sites have most or all of their “virulent” residues in the 10
sequences from the 2004 Vietnam/Thailand outbreak.
To mitigate the potential bias in the results introduced by
nonindependence, an alternative approach would be to code
each sequence for the presence or absence of mutations com-
pared to its immediate inferred ancestral sequence (using a
phylogenetic tree and model of sequence evolution). The
change in the viral phenotype from the ancestral sequences
would also have to be inferred. However, although this ap-
proach was successfully used to find mutations in the HIV
envelope protein (60, 61), it cannot be applied to a data set
where each segment has its own evolutionary history (22, 77,
80) since reassortment of the internal genes with other sub-
types means that no single tree is applicable to all eight seg-
ments. Recognizing the issue, we reduced potential biases in-
curred due to the relationships between the sequences by using
a relatively wide range of isolates (spanning more than 10
years) and selection of sites with dissimilar mutation patterns
across the strains.
We used several techniques to reduce other potential
sources of error in the model. First, backed by simulation
studies investigating the number of false-positive associations
as a function of data set size and number of sites, we limited
the number of sites in our analysis to those with prior evidence
from the literature and the strongest univariate associations to
virulence in mammals. Second, we used cross-validation to
reduce the effects of sequence misclassification (and sequence
errors): the model presented here is an average over 10 sub-
samples of the data. Third, we used permutation tests to vali-
date the significance of the associations against the null model
of association by chance.
Using the model, we estimated the probability of virulence
in mammals for strains containing different combinations of
influencing sites. To evaluate the prediction performance of
the model, we predicted each sequence in the cross-validation
test data sets as virulent or nonvirulent on the basis of the
combination of mutations it contained and compared the re-
sults to the original values. The high specificity (95%) indicates
the model yields few false positives, but the lower sensitivity
(70%) indicates that not all virulence determinants may have
been captured as a result of the small size of the data set. Noise
and experimental errors in the data are also expected to reduce
the classification performance. The performance of the model
compares well with other models relating viral mutations to
phenotype, e.g., sensitivity in the range 40 to 100% (70% was
typical) and a specificity of ca. 70% have been reported for
HIV drug resistance models (42).
In conclusion, we have collated experimental data about the
virulence of HPAI H5N1 strains in mammals and used it to
identify its genetic basis by inferring a BGM of whole-genome
mutations affecting the phenotype. We used data from strains
isolated over a period of at least 10 years and analyzed the
results obtained in 27 studies so our conclusions are general
rather than specific to a single experimental system. The re-
sulting statistical model reveals the polygenic nature of viru-
lence in mammals: mutations at PB1-317, PB2-355, NS1-92,
NS1-228, NS1-195 and HA-102(86) are directly associated with
the trait. These sites split into two semi-independent groups,
possibly indicating separate virulence mechanisms: PB1-317,
PB2-355, NS1-92, and NS1-228 mutations were strongly corre-
lated with each other, as were NS1-195 and HA-102(86). We
also found strong correlation patterns in the PB1, PB2, and PA
sites; the antigenic sites and a variable glycosylation site in HA;
and the HA and NS sites. The results highlight the importance
of the polymerase and nonstructural internal genes in addition
to HA in determining the virulence of HPAI H5N1 in mam-
mals and identify potential targets for intervention in mamma-
lian H5N1 infections.
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